WallStreetZenWallStreetZen

NASDAQ: IOVA
Iovance Biotherapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for IOVA

Based on 4 analysts offering 12 month price targets for Iovance Biotherapeutics Inc.
Min Forecast
$10.00-0.1%
Avg Forecast
$22.75+127.27%
Max Forecast
$32.00+219.68%

Should I buy or sell IOVA stock?

Based on 4 analysts offering ratings for Iovance Biotherapeutics Inc.
Buy
Strong Buy
1 analysts 25%
Buy
2 analysts 50%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IOVA stock forecasts and price targets.

IOVA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-12
lockedlocked$00.00+00.00%2024-07-29
lockedlocked$00.00+00.00%2024-06-20

1 of 1

Forecast return on equity

Is IOVA forecast to generate an efficient return?
Company
34.36%
Industry
-388.9%
Market
58.96%
IOVA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IOVA forecast to generate an efficient return on assets?
Company
27.38%
Industry
27.36%
IOVA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IOVA earnings per share forecast

What is IOVA's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
-$1.27
Avg 2 year Forecast
-$0.79
Avg 3 year Forecast
-$0.01

IOVA revenue forecast

What is IOVA's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$161.7M+393.4%
Avg 2 year Forecast
$454.4M+1,286.68%
Avg 3 year Forecast
$629.1M+1,819.58%
IOVA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IOVA revenue growth forecast

How is IOVA forecast to perform vs Biotechnology companies and vs the US market?
Company
171.37%
Industry
34.96%
Market
9.31%
IOVA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IOVA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IOVA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IOVA$10.01$22.75+127.27%Buy
IDYA$36.21$57.00+57.42%Strong Buy
RYTM$49.25$57.00+15.74%Strong Buy
MLTX$46.02$82.00+78.18%Buy
XENE$38.47$57.80+50.25%Strong Buy
View Top Biotech Stocks

Iovance Biotherapeutics Stock Forecast FAQ

Is Iovance Biotherapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: IOVA) stock is to Buy IOVA stock.

Out of 4 analysts, 1 (25%) are recommending IOVA as a Strong Buy, 2 (50%) are recommending IOVA as a Buy, 1 (25%) are recommending IOVA as a Hold, 0 (0%) are recommending IOVA as a Sell, and 0 (0%) are recommending IOVA as a Strong Sell.

If you're new to stock investing, here's how to buy Iovance Biotherapeutics stock.

What is IOVA's earnings growth forecast for 2024-2026?

(NASDAQ: IOVA) Iovance Biotherapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.

Iovance Biotherapeutics's earnings in 2024 is -$440,216,000.On average, 8 Wall Street analysts forecast IOVA's earnings for 2024 to be -$383,945,048, with the lowest IOVA earnings forecast at -$461,341,085, and the highest IOVA earnings forecast at -$254,951,652. On average, 7 Wall Street analysts forecast IOVA's earnings for 2025 to be -$239,351,039, with the lowest IOVA earnings forecast at -$355,111,230, and the highest IOVA earnings forecast at -$136,581,242.

In 2026, IOVA is forecast to generate -$4,249,194 in earnings, with the lowest earnings forecast at -$157,827,213 and the highest earnings forecast at $367,251,785.

What is IOVA's revenue growth forecast for 2024-2026?

(NASDAQ: IOVA) Iovance Biotherapeutics's forecast annual revenue growth rate of 171.37% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.96%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.31%.

Iovance Biotherapeutics's revenue in 2024 is $32,772,000.On average, 7 Wall Street analysts forecast IOVA's revenue for 2024 to be $49,077,586,075, with the lowest IOVA revenue forecast at $48,237,459,677, and the highest IOVA revenue forecast at $49,867,329,170. On average, 7 Wall Street analysts forecast IOVA's revenue for 2025 to be $137,930,058,047, with the lowest IOVA revenue forecast at $132,887,478,578, and the highest IOVA revenue forecast at $143,865,575,328.

In 2026, IOVA is forecast to generate $190,935,720,653 in revenue, with the lowest revenue forecast at $121,818,327,666 and the highest revenue forecast at $256,772,735,712.

What is IOVA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: IOVA) forecast ROA is 27.38%, which is higher than the forecast US Biotechnology industry average of 27.36%.

What is IOVA's Price Target?

According to 4 Wall Street analysts that have issued a 1 year IOVA price target, the average IOVA price target is $22.75, with the highest IOVA stock price forecast at $32.00 and the lowest IOVA stock price forecast at $10.00.

On average, Wall Street analysts predict that Iovance Biotherapeutics's share price could reach $22.75 by Aug 12, 2025. The average Iovance Biotherapeutics stock price prediction forecasts a potential upside of 127.27% from the current IOVA share price of $10.01.

What is IOVA's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: IOVA) Iovance Biotherapeutics's current Earnings Per Share (EPS) is -$1.67. On average, analysts forecast that IOVA's EPS will be -$1.27 for 2024, with the lowest EPS forecast at -$1.52, and the highest EPS forecast at -$0.84. On average, analysts forecast that IOVA's EPS will be -$0.79 for 2025, with the lowest EPS forecast at -$1.17, and the highest EPS forecast at -$0.45. In 2026, IOVA's EPS is forecast to hit -$0.01 (min: -$0.52, max: $1.21).

What is IOVA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: IOVA) forecast ROE is 34.36%, which is considered strong.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.